Serenus.AI Overview
Serenus.AI specializes in the development of advanced Generative AI technologies that empower medical decisions at critical medical crossroads on patient pathways, saving lives and valuable resources. Our flagship product is the first (registered patent and 4 patents pending) clinically objective, Generative AI, automated case-by-case system to improve decision-making before medical procedures and treatments, while prioritizing patients' waiting lists. Serenus.AI advanced the quality and equality of healthcare delivery, saves valuable resources, and boosts patients', physicians', and payers' satisfaction across the board. The system's algorithms replicate the objective decision-making processes of top physicians by combining up-to-date medical practices, professional knowledge, and machine-learning technologies. The Serenus.AI solution is compatible with every type of health system, including US insurance companies and public health systems. The solution has been validated in practice, and the company is currently active in Europe and the United States with stakeholders in the healthcare field.
Cumulative Funding Raised Over Time ($)
$1.9MJul 2018
Latest News
growth-positive
Serenus.AI Granted New US Patent for 'AUTOMATED METHOD AND SYSTEM FOR SCREENING AND PREVENTION OF UNNECESSARY MEDICAL PROCEDURES'
Serenus.AI, an innovative startup developing AI-based solutions to improve medical treatment decisions, has obtained a Notice of Allowance from the US Patent and Trademark Office for its patent application. The patent focuses on screening and prevention of unnecessary medical procedures. This adds to Serenus.AIs intellectual property portfolio and highlights the companys uniqueness and innovation in the US healthcare market. The problem of unnecessary medical procedures is a burden on healthcare systems, especially during emergencies like the COVID-19 pandemic. Serenus.AI aims to improve healthcare delivery, minimize risks, and save valuable resources. The companys flagship product is an AI-based review system to improve utilization and prior authorization processes before medical procedures. Serenus.AI has a world-class team and is currently active in Europe and the US with leading healthcare stakeholders.
CustomersPartners
growth-positive
Serenus.AI - Innovative AI-based technology for improved medical treatment decisions
Serenus.AI Ltd., an AI-based healthcare solution provider, has developed a platform that assists patients, medical professionals, health systems, and insurers in making better medical treatment decisions. The platform uses unique algorithms to replicate the decision-making process of top physicians, combining medical practice guidance, professionals knowledge, and machine learning technologies. Serenus.AI has recently partnered with HealthTrio to launch an AI Prior-Auth Connect solution, aimed at simplifying medical pre-authorization clinical decision making. The company has already developed modules for 30 common and costly elective procedures, reducing medical and administrative costs for customers. Serenus.AI is active in Israel, the USA, and the UK and has received awards and grants for its innovative technology.
CustomersPartners
growth-positive
Serenus.AI and HealthTrio team up to innovate the authorization process through the use of advanced machine learning
Serenus.AI and HealthTrio LLC are partnering to launch AI Prior-Auth Connect, a platform that uses AI technologies to streamline and automate the process for medical prior authorizations. The collaboration aims to improve and simplify the healthcare process, advance quality of care, and save valuable resources. The platform will enable providers and payers to streamline the authorizations process, allowing faster and more accurate responses based on customizable plan policy. Serenus.AI is an innovative startup focused on optimizing medical decisions, while HealthTrio provides digital engagement solutions for healthcare consumerism. The partnership combines their expertise to deliver a solution that takes the healthcare system to the next level.
Partners
BIRD to invest $8 Million in 10 New Projects - BIRD Foundation
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | $2.7M |
| Last funding | $800K |
| Stage | Seed |
| Rounds | 2 |
| Investors | 4 |
Team Members
3
Employees: 1-10
Web & Social Links
| Website | www.serenusai.com |
| Careers | Careers page |
Locations
Rofe ha-Makhtarot St 32, Tel Aviv-Yafo, Israel
Photos & Videos
2 item(s)
Serenus.AI Business
Business models
B2B
Product stage
Released
Employees
1-10
Sector
Health Tech & Life SciencesDigital HealthcareMedical Decision SupportTarget Customer
Healthcare & Life SciencesHealthcareProvidersCore Technology
Artificial IntelligenceDeep LearningTags (15)
pharma-companiesinsurtechhealthcaredata-analyticsemrmachine-learningdeep-learningartificial-intelligenceinsurance-companieshealthcare-providersdigital-healthcaredecision-makingcloud-baseddecision-supportclinical-trialsGeographic Markets
United KingdomEuropeUnited StatesIsraelSerenus.AI Financials
$2.7M
Total funding
Undisclosed
Capital raised
$800K
Last funding
Seed
Funding stage
2
Total rounds
4
Investors
Cumulative Funding Raised Over Time ($)
$1.9MJul 2018
Private Equity Funding
Seed
Jul 2018
$1.9M
Firstime VC, thetime, Shibolet, Madanes
Non-Equity Funding
GrantEvent
Jul 2020
$800K
BIRD Foundation
Serenus.AI Lifecycle
Cumulative Funding Raised Over Time
$1.9MJul 2018
All Events
Seed
Jul 2018
$1.9M
Firstime VC, thetime, Shibolet, Madanes
GrantEvent
Jul 2020
$800K
BIRD Foundation
Serenus.AI News
4 articles
growth-positive
Serenus.AI Granted New US Patent for 'AUTOMATED METHOD AND SYSTEM FOR SCREENING AND PREVENTION OF UNNECESSARY MEDICAL PROCEDURES'
Serenus.AI, an innovative startup developing AI-based solutions to improve medical treatment decisions, has obtained a Notice of Allowance from the US Patent and Trademark Office for its patent application. The patent focuses on screening and prevention of unnecessary medical procedures. This adds to Serenus.AIs intellectual property portfolio and highlights the companys uniqueness and innovation in the US healthcare market. The problem of unnecessary medical procedures is a burden on healthcare systems, especially during emergencies like the COVID-19 pandemic. Serenus.AI aims to improve healthcare delivery, minimize risks, and save valuable resources. The companys flagship product is an AI-based review system to improve utilization and prior authorization processes before medical procedures. Serenus.AI has a world-class team and is currently active in Europe and the US with leading healthcare stakeholders.
CustomersPartners
growth-positive
Serenus.AI - Innovative AI-based technology for improved medical treatment decisions
Serenus.AI Ltd., an AI-based healthcare solution provider, has developed a platform that assists patients, medical professionals, health systems, and insurers in making better medical treatment decisions. The platform uses unique algorithms to replicate the decision-making process of top physicians, combining medical practice guidance, professionals knowledge, and machine learning technologies. Serenus.AI has recently partnered with HealthTrio to launch an AI Prior-Auth Connect solution, aimed at simplifying medical pre-authorization clinical decision making. The company has already developed modules for 30 common and costly elective procedures, reducing medical and administrative costs for customers. Serenus.AI is active in Israel, the USA, and the UK and has received awards and grants for its innovative technology.
CustomersPartners
growth-positive
Serenus.AI and HealthTrio team up to innovate the authorization process through the use of advanced machine learning
Serenus.AI and HealthTrio LLC are partnering to launch AI Prior-Auth Connect, a platform that uses AI technologies to streamline and automate the process for medical prior authorizations. The collaboration aims to improve and simplify the healthcare process, advance quality of care, and save valuable resources. The platform will enable providers and payers to streamline the authorizations process, allowing faster and more accurate responses based on customizable plan policy. Serenus.AI is an innovative startup focused on optimizing medical decisions, while HealthTrio provides digital engagement solutions for healthcare consumerism. The partnership combines their expertise to deliver a solution that takes the healthcare system to the next level.
Partners
BIRD to invest $8 Million in 10 New Projects - BIRD Foundation
Serenus.AI Team
Employee Info
| Employees (range) | 1-10 |
| Exact count | 5 |
| Team members | 3 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 8 classification IDs that could be used for matching.
Serenus.AI Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 100/100 |
| Missing | markets |
| BI Verification | Jenny Sotnik-Talisman |
| Registrar ID | 515549145 |
| Crunchbase | medecide |
| Phone | +972543155222 |
| Creator | Paz Eliav |
| Creator email | paze@cet.ac.il |
| Last updater | Yanina Wainscheinker |
| Updater email | yanina.wainscheinker@sncentral.org |
| Last update | 2022-10-17T00:00:00.000Z |
| Created | 2016-12-21T00:00:00.000Z |
| Claimed | Yes |